Skip to main content
. 2012 May;8(3 Suppl):e6s–e13s. doi: 10.1200/JOP.2012.000539

Table 1.

Descriptive Characteristics of End-of-Life Cancer Cohort of Medicare Beneficiaries Dying With Poor-Prognosis Cancer: 2003 to 2007

Characteristic Decedent Cancer Cohort
Lung Cancer Cohort
Total Received Chemotherapy in Last 6 Months of Life
Total Received Chemotherapy in Last 6 Months of Life
Physician Office Only Outpatient Department Only Both Settings Physician Office Only Outpatient Department Only Both Settings
No. of patients 235,821 55,450 15,503 4,073 74,581 18,857 4,610 1,155
Age at death, years 78.1 76.0 74.7 74.5 76.9 74.7 73.9 73.9
Black race, % 9.2 8.0 10.2 8.2 8.4 7.0 10.2 8.0
Female sex, % 48.6 41.7 46.9 44.1 44.4 39.2 41.2 38.5
Zip code
    Income level, $ 44,482 45,459 45,240 45,760 43,675 44,740 43,258 44,101
    Poverty rate, % 10.5 10.0 10.5 9.9 10.6 10.0 11.1 10.4
Type of cancer, %
    Metastatic 54.7 66.2 67.1 67.1 48.0 61.2 62.1 64.7
    Lung 31.6 34.0 29.7 28.4
    Breast 5.3 7.5 8.0 7.4
    Prostate 5.9 12.7 6.3 10.2
    Pancreatic 6.4 6.4 6.5 6.7
    Hematologic 8.9 7.1 8.3 10.7
    Colorectal 8.1 9.5 9.4 10.2
    Liver 3.1 1.3 1.8 1.5
    Unknown primary 9.6 3.1 5.8 2.7
Comorbidities, %
    Chronic pulmonary disease 42.0 40.3 36.2 35.1 68.1 67.1 63.1 64.5
    Coronary artery disease 31.2 29.6 25.7 26.2 34.2 32.9 30.3 30.4
    Congestive heart failure 30.3 25.9 21.9 24.5 32.1 27.2 24.5 28.1
    Peripheral vascular disease 9.8 8.3 7.0 6.7 12.3 10.8 9.9 9.4
    Severe chronic liver disease 2.3 1.2 1.7 1.0 0.9 0.6 0.8 0.5
    Diabetes with end organ damage 4.2 3.5 3.2 3.3 3.6 3.1 3.0 2.8
    Chronic renal failure 12.2 10.5 9.0 8.5 9.7 7.2 7.2 5.2
    Dementia 10.6 4.6 3.8 2.9 9.5 3.6 3.6 3.0
Year of death, %
    2003 20.4 20.8 17.2 23.4 20.4 21.0 17.4 22.9
    2004 20.4 21.2 18.6 24.3 20.3 20.8 19.3 26.0
    2005 20.4 20.8 20.2 24.1 20.5 21.0 20.0 22.6
    2006 19.6 19.0 21.3 14.1 19.7 19.2 20.5 13.8
    2007 19.2 18.2 22.7 14.1 19.2 18.0 22.8 14.7
Outcomes, %
    Received chemotherapy in last 6 months of life 32 100 100 100 33 100 100 100
    Received chemotherapy in last 3 months of life 77 77 73 89 79 79 74 87
    Received chemotherapy in last 14 days of life 15 16 12 19 17 18 13 21
No. of chemotherapy treatments (among receivers)
    Last 6 months of life 6.7 6.7 5.5 10.1 7.0 7.1 5.6 10.0
    Last 3 months of life 4.1 4.1 3.4 5.5 4.3 4.3 3.5 5.7
    Last 14 days of life 1.5 1.5 1.4 1.6 1.5 1.5 1.4 1.8